Highly specialized clinic for benign and malignant thyroid diseases, offering the full spectrum of modern diagnostic and therapeutic options
Scintigraphy (SPECT and SPECT/CT) for diseases of the thyroid, skeleton, myocardium, lungs, kidneys and brain. Visualization of lymphatic drainage for sentinel lymph node resection
PET & PET/CT (64-slice CT and time-of-flight PET imaging) with numerous molecular imaging probes for:
- Oncology: Detection, staging and treatment monitoring of cancer, in particular lung cancer, lymphoma, gastrointestinal malignancies, prostate cancer, melanoma, neuroendocrine tumors and brain tumors. Molecular imaging targets include glucose, protein and cell membrane metabolism and transport, hormone receptors, perfusion and hypoxia. PET-based radiation treatment planning, especially for stereotactic and intensity modulated radiotherapy.
- Neurology: State-of-the-art diagnostics, differential diagnostics and follow-up of neurodegenerative disorders, most notably including dementia (e.g., Alzheimer’s disease) and movement disorders (e.g., Parkinson’s disease, Huntington’s disease). Localization of epileptogenic foci in patients with seizures. Molecular imaging target include glucose metabolism, dopamine synthesis and storage, cerebral perfusion, a variety of neurotransmitter receptors and transporters (dopaminergic serotonergic neurotransmission) and beta-amyloid imaging.
- Cardiology: Detection of viable myocardium in patients with coronary artery disease prior to revascularization.
Molecular Therapy
- Radioiodine therapy of hyperthyroidism
- Radioiodine therapy and targeted therapies in thyroid cancer
- Targeted radionuclide therapy of neuroendocrine tumors, including DOTATOC and DOTATATE radiopeptide theapy
- Treatment of lymphoma with radiolabeled anti-CD20 antibodies
- Treatment of primary and secondary liver tumors with selective internal radiation therapy (SIRT)
- Treatment of bone pain secondary to metastases
